共 50 条
Research progress on RNA-binding proteins in breast cancer
被引:10
|作者:
Chen, Ying
[1
]
Qin, Hai
[2
]
Zheng, Lufeng
[1
]
机构:
[1] China Pharmaceut Univ, Sch Life Sci & Technol, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Peoples R China
[2] Guizhou Prov Orthoped Hosp, Dept Clin Lab, Guiyang, Peoples R China
来源:
FRONTIERS IN ONCOLOGY
|
2022年
/
12卷
基金:
中国国家自然科学基金;
关键词:
breast cancer;
RNA-binding proteins;
research progress;
mRNA;
3'UTR;
MESSENGER-RNA;
TRANSLATIONAL INHIBITION;
MESENCHYMAL TRANSITION;
SIGNAL-TRANSDUCTION;
PROGNOSTIC VALUE;
STRUCTURAL BASIS;
PROSTATE-CANCER;
IN-VITRO;
TARGET;
EXPRESSION;
D O I:
10.3389/fonc.2022.974523
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Breast cancer is the most common malignancy in women and has a high incidence rate and mortality. Abnormal regulation of gene expression plays an important role in breast cancer occurrence and development. RNA-binding proteins (RBPs) are one kind of the key regulators for gene expression. By interacting with RNA, RBPs are widely involved in RNA cutting, transport, editing, intracellular localization, and translation regulation. RBPs are important during breast cancer occurrence and progression by engaging in many aspects, like proliferation, migration, invasion, and stemness. Therefore, comprehensively understanding the role of RBPs in breast cancer progression can facilitate early diagnosis, timely treatment, and long-term survival and quality of life of breast cancer patients.
引用
收藏
页数:12
相关论文